Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune function determination in patients with bladder cancer.

S A Brosman, J L Fahey

    National Cancer Institute Monograph
    |December 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India.

    AIDS research and treatment·2012
    Same author

    Continuing medical education on antiretroviral therapy in HIV/AIDS in India: needs assessment and impact on clinicians and allied health personnel.

    The National medical journal of India·2010
    Same author

    Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Idiopathic CD4+ T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy.

    Clinical immunology (Orlando, Fla.)·2001
    Same author

    Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.

    The Journal of infectious diseases·2000
    Same author

    Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons.

    Clinical and diagnostic laboratory immunology·2000
    Same journal

    Forty-five years of cancer incidence in Connecticut: 1935-79.

    National Cancer Institute monograph·1986
    Same journal

    Second cancer following cancer of the breast in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the respiratory system in Connecticut, 1935-1982.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the digestive system in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Summary: multiple primary cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    See all related articles

    This study evaluated bladder cancer patients to understand the relationship between their immune system response and the cancer

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Bladder cancer presents a significant clinical challenge.
    • Understanding immune system interactions is crucial for treatment strategies.

    Purpose of the Study:

    • To clinically evaluate bladder cancer patients.
    • To correlate the stage of bladder cancer with immune responsiveness.

    Main Methods:

    • Clinical evaluation of patients with bladder cancer.
    • Application of a battery of tests to assess immune responsiveness.
    • Correlation analysis between disease stage and immune metrics.

    Main Results:

    • The study describes a methodology to assess immune responsiveness in bladder cancer patients.
    • The described tests aim to link disease stage with immune status.

    Related Experiment Videos

    Conclusions:

    • The developed testing battery provides a framework for correlating bladder cancer stage with immune responsiveness.
    • Further research can utilize this framework to explore immunotherapeutic approaches.